Biologic Drugs Market Report

Global and Regional Biologic Drugs Market Details Research Report 2021-2026

  • POSTDATE：Jun 26, 2021
  • PAGES：222
  • REPORT CODE：GMM729080
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Global Biologic Drugs Market Report provides evaluation of the market development from historical studies. This report further provides forecasts by performing comprehensive market analysis.  It covers thorough market analysis for the forecasted period 2021-2026. Moreover, this market study focuses on market classification into different segments along with thorough analysis of the competitors, key players and their profiles. The market size is calculated on the basis of revenue generated and volume.  Knowing dynamics of the market plays an important role and this report sheds light on dynamics like drivers and restraints.

    Such comprehensive Biologic Drugs market report further covers factors that influence market along with potent developing factors for various End-users, Types and Regions to outline the most capturing development trends of the Hydraulic Work Supports Industry. In addition, it focuses on some prominent investment sectors in regions such as Latin America, Europe, Asia Pacific, Africa and Middle East. This unique market report presents precious opinion of strategic adjustments for new key entrant as well present groups. In this research analysis, market capacity and consumption potential of prominent players are mentioned.

    In 2020, COVID-19 has had a certain impact on the global economy, so the report considers the impact of COVID-19 on the Global Biologic Drugs market.

    By Player:

    • Roche

    • Johnson & Johnson

    • Pfizer

    • Sanofi

    • Amgen

    • Eli Lilly

    • Novartis

    • Abbott Laboratories

    • Amgen

    • Eli Lilly

    By Type:

    • Humira

    • Remicade

    • Rituxan

    • Enbrel

    • Lantus

    • Avastin

    • Herceptin

    • Others

    By End-User:

    • Diabetes

    • Inflammation

    • Auto-Immune Diseases

    • Blood Diseases

    • Cardiovascular Diseases

    • Others

    By Geography:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • United Kingdom

    • France

    • Italy

    • Russia

    • Spain

    • Netherlands

    • Switzerland

    • Turkey

    • Poland

    • Sweden

    • Belgium

    • Austria

    • Others

    Asia

    • China

    • Japan

    • India

    • South Korea

    • Indonesia

    • Thailand

    • Malaysia

    • Singapore

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Argentina

    • Colombia

    • Chile

    • Others

    Middle East

    • United Arab Emirates (UAE)

    • Saudi Arabia

    • Others

    Africa

    • Nigeria

    • Egypt

    • South Africa

    • Others

    Oceania

    • Australia

    • New Zealand

    • Others


    Major Reasons to Buy this Report

    This market report is the perfect presentation of the qualitative and quantitative analysis of the market according to categorization considering economic and non-economic factors.

    • It also provides provision of market value (USD Million) data for every segment and sub-segment.

    • This report further focuses on prominent regions and segmentation of the market, which is anticipated to record the rapid growth and dominate the market.

    • Market analysis is done on the basis of major regions covering consumption of the product in particular region and factors affecting the market growth in every region.

    • This market report further sheds light on competitive landscape, which indicates the place of the prominent key players in the market. It also covers a few crucial market strategies followed by the major players of the market such as partnerships, new service launches, business expansions and acquisitions of the companies profiled during last five years.

    • This market study sheds light on a wide range of company profiles, which contain company insights, SWOT analysis for the prominent industry players, company overview and product benchmarking.

    • The present and future market outlook of the industry is also mentioned in this unique market report along with recent development such as drivers, opportunities, challenges and market restricting factors of developed and rising regions.  

    • This market report is the unique depiction of porter’s five forces analysis, which is performed thorough analysis of the market perspectives.  Insights into market scenario is provided through value chain

    •  It further focuses on growth opportunities of upcoming years and depicts market scenario along with market dynamics.

    • This market report also provides six month post-sales analyst support.


    Customization of the Report

    Please feel free to contact our sales team in case of any Query or Customization Requirements. Our expert team will give you right solutions for your query.

  • TABLE OF CONTENT

    1 Biologic Drugs Market Overview

    • 1.1 Product Definition and Study Scope

      • 1.1.1 Study Scope by Types

      • 1.1.2 Study Scope by Application

    • 1.2 Market Overview and Trends

      • 1.2.1 Global Biologic Drugs Market Size and Growth Rate from 2016 to 2026

      • 1.2.2 Market Overview (Current Market Status)

      • 1.2.3 Qualitative Analysis of Market Trends

    • 1.3 Business Environment Analysis Tools

      • 1.3.1 PESTEL Analysis

      • 1.3.2 Porter's Five Forces Analysis

      • 1.3.3 Major Deals & Strategic Alliances Analysis

    2 Major Players Market Position

    • 2.1 Global Biologic Drugs Production Capacity and Market Share by Manufacturers (2016-2021)

    • 2.2 Global Biologic Drugs Market Revenue and Market Share by Manufacturers (2016-2021)

    • 2.3 Global Biologic Drugs Market Revenue and Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • 2.4 Manufacturers Biologic Drugs Plant Distribution and Sales Country

    3 Key Competitor and Financial Performance

    • 3.1 Roche

      • 3.1.1 Roche - Company Business Overview

      • 3.1.2 Roche - Company Financial Performance

      • 3.1.3 Roche - Company Financial Performance of Biologic Drugs

      • 3.1.4 Biologic Drugs Product Benchmarking

      • 3.1.5 Strategic Initiatives

    • 3.2 Johnson & Johnson

      • 3.2.1 Johnson & Johnson - Company Business Overview

      • 3.2.2 Johnson & Johnson - Company Financial Performance

      • 3.2.3 Johnson & Johnson - Company Financial Performance of Biologic Drugs

      • 3.2.4 Biologic Drugs Product Benchmarking

      • 3.2.5 Strategic Initiatives

    • 3.3 Pfizer

      • 3.3.1 Pfizer - Company Business Overview

      • 3.3.2 Pfizer - Company Financial Performance

      • 3.3.3 Pfizer - Company Financial Performance of Biologic Drugs

      • 3.3.4 Biologic Drugs Product Benchmarking

      • 3.3.5 Strategic Initiatives

    • 3.4 Sanofi

      • 3.4.1 Sanofi - Company Business Overview

      • 3.4.2 Sanofi - Company Financial Performance

      • 3.4.3 Sanofi - Company Financial Performance of Biologic Drugs

      • 3.4.4 Biologic Drugs Product Benchmarking

      • 3.4.5 Strategic Initiatives

    • 3.5 Amgen

      • 3.5.1 Amgen - Company Business Overview

      • 3.5.2 Amgen - Company Financial Performance

      • 3.5.3 Amgen - Company Financial Performance of Biologic Drugs

      • 3.5.4 Biologic Drugs Product Benchmarking

      • 3.5.5 Strategic Initiatives

    • 3.6 Eli Lilly

      • 3.6.1 Eli Lilly - Company Business Overview

      • 3.6.2 Eli Lilly - Company Financial Performance

      • 3.6.3 Eli Lilly - Company Financial Performance of Biologic Drugs

      • 3.6.4 Biologic Drugs Product Benchmarking

      • 3.6.5 Strategic Initiatives

    • 3.7 Novartis

      • 3.7.1 Novartis - Company Business Overview

      • 3.7.2 Novartis - Company Financial Performance

      • 3.7.3 Novartis - Company Financial Performance of Biologic Drugs

      • 3.7.4 Biologic Drugs Product Benchmarking

      • 3.7.5 Strategic Initiatives

    • 3.8 Abbott Laboratories

      • 3.8.1 Abbott Laboratories - Company Business Overview

      • 3.8.2 Abbott Laboratories - Company Financial Performance

      • 3.8.3 Abbott Laboratories - Company Financial Performance of Biologic Drugs

      • 3.8.4 Biologic Drugs Product Benchmarking

      • 3.8.5 Strategic Initiatives

    • 3.9 Amgen

      • 3.9.1 Amgen - Company Business Overview

      • 3.9.2 Amgen - Company Financial Performance

      • 3.9.3 Amgen - Company Financial Performance of Biologic Drugs

      • 3.9.4 Biologic Drugs Product Benchmarking

      • 3.9.5 Strategic Initiatives

    • 3.10 Eli Lilly

      • 3.10.1 Eli Lilly - Company Business Overview

      • 3.10.2 Eli Lilly - Company Financial Performance

      • 3.10.3 Eli Lilly - Company Financial Performance of Biologic Drugs

      • 3.10.4 Biologic Drugs Product Benchmarking

      • 3.10.5 Strategic Initiatives

    4 Global Biologic Drugs Market Segment Analysis (Types Level)

    • 4.1 Purchasing Strategy based on Purchasing Positioning Model

    • 4.2 Global Biologic Drugs Market Revenue and Market Share by Types (Historical)

      • 4.2.1 Global Revenue and Growth Rate of Humira 2016-2021

      • 4.2.2 Global Revenue and Growth Rate of Remicade 2016-2021

      • 4.2.3 Global Revenue and Growth Rate of Rituxan 2016-2021

      • 4.2.4 Global Revenue and Growth Rate of Enbrel 2016-2021

      • 4.2.5 Global Revenue and Growth Rate of Lantus 2016-2021

      • 4.2.6 Global Revenue and Growth Rate of Avastin 2016-2021

      • 4.2.7 Global Revenue and Growth Rate of Herceptin 2016-2021

      • 4.2.8 Global Revenue and Growth Rate of Others 2016-2021

    • 4.3 Global Biologic Drugs Market Sales and Market Share by Types (Historical)

      • 4.3.1 Global Sales and Growth Rate of Humira 2016-2021

      • 4.3.2 Global Sales and Growth Rate of Remicade 2016-2021

      • 4.3.3 Global Sales and Growth Rate of Rituxan 2016-2021

      • 4.3.4 Global Sales and Growth Rate of Enbrel 2016-2021

      • 4.3.5 Global Sales and Growth Rate of Lantus 2016-2021

      • 4.3.6 Global Sales and Growth Rate of Avastin 2016-2021

      • 4.3.7 Global Sales and Growth Rate of Herceptin 2016-2021

      • 4.3.8 Global Sales and Growth Rate of Others 2016-2021

    • 4.4 Global Biologic Drugs Market Revenue and Market Share by Types (Forecast)

    • 4.5 Global Biologic Drugs Market Sales and Market Share by Types (Forecast)

    • 4.6 Global Biologic Drugs Market Price By Type from 2016 to 2026

    5 Global Biologic Drugs Market Segment Analysis (Application Level)

    • 5.1 Downstream Industry Demand Analysis of Biologic Drugs

    • 5.2 Global Biologic Drugs Market Revenue and Market Share by Application (Historical)

      • 5.2.1 Global Revenue and Growth Rate of Diabetes 2016-2021

      • 5.2.2 Global Revenue and Growth Rate of Inflammation 2016-2021

      • 5.2.3 Global Revenue and Growth Rate of Auto-Immune Diseases 2016-2021

      • 5.2.4 Global Revenue and Growth Rate of Blood Diseases 2016-2021

      • 5.2.5 Global Revenue and Growth Rate of Cardiovascular Diseases 2016-2021

      • 5.2.6 Global Revenue and Growth Rate of Others 2016-2021

    • 5.3 Global Biologic Drugs Market Sales and Market Share by Application (Historical)

      • 5.3.1 Global Sales and Growth Rate of Diabetes 2016-2021

      • 5.3.2 Global Sales and Growth Rate of Inflammation 2016-2021

      • 5.3.3 Global Sales and Growth Rate of Auto-Immune Diseases 2016-2021

      • 5.3.4 Global Sales and Growth Rate of Blood Diseases 2016-2021

      • 5.3.5 Global Sales and Growth Rate of Cardiovascular Diseases 2016-2021

      • 5.3.6 Global Sales and Growth Rate of Others 2016-2021

    • 5.4 Global Biologic Drugs Market Revenue and Market Share by Application (Forecast)

    • 5.5 Global Biologic Drugs Market Sales and Market Share by Application (Forecast)

    6 Global Biologic Drugs Market Segment Analysis (Geography Level)

    • 6.1 Global Biologic Drugs Market Revenue and Market Share by Geography (Historical)

    • 6.2 Global Biologic Drugs Market Sales and Market Share by Geography (Historical)

    • 6.3 Global Biologic Drugs Market Revenue and Market Share by Geography (Forecast)

    • 6.4 Global Biologic Drugs Market Sales and Market Share by Geography (Forecast)

    • 6.5 Top Sales Country Advantage Analysis

    • 6.6 Top 5 Export Countries in Biologic Drugs Market from 2016 to 2020

    • 6.7 Top 5 Import Countries in Biologic Drugs Market from 2016 to 2020

    7. North America Biologic Drugs Market Segment Analysis and Investment Attractiveness

    • 7.1 North America Biologic Drugs Market Segment by Countries

      • 7.1.1 North America Biologic Drugs Market Revenue Segment by Countries

      • 7.1.2 North America Biologic Drugs Market Sales Segment by Countries

      • 7.1.3 USA

      • 7.1.4 Canada

      • 7.1.5 Mexico

    • 7.2 North America Biologic Drugs Market Segment (Product Type Level)

    • 7.3 North America Biologic Drugs Market Segment (Application/Industry Level)

    • 7.4 Key Country Economy in North America

    • 7.5 Analysis of Investment Attractiveness of Major Countries

    8 Europe Biologic Drugs Market Segment Analysis and Investment Attractiveness

    • 8.1 Europe Biologic Drugs Market Segment by Countries

      • 8.1.1 Europe Biologic Drugs Market Revenue Segment by Countries

      • 8.1.2 Europe Biologic Drugs Market Sales Segment by Countries

      • 8.1.3 Germany

      • 8.1.4 United Kingdom

      • 8.1.5 France

      • 8.1.6 Italy

      • 8.1.7 Russia

      • 8.1.8 Spain

      • 8.1.9 Netherlands

      • 8.1.10 Switzerland

      • 8.1.11 Turkey

      • 8.1.12 Poland

      • 8.1.13 Sweden

      • 8.1.14 Belgium

      • 8.1.15 Austria

      • 8.1.16 Others

    • 8.2 Europe Biologic Drugs Market Segment (Product Type Level)

    • 8.3 Europe Biologic Drugs Market Segment (Application/Industry Level)

    • 8.4 Key Country Economy in Europe

    • 8.5 Analysis of Investment Attractiveness of Major Countries

    9 Asia Biologic Drugs Market Segment Analysis and Investment Attractiveness

    • 9.1 Asia Biologic Drugs Market Segment by Countries

      • 9.1.1 Asia Biologic Drugs Market Revenue Segment by Countries

      • 9.1.2 Asia Biologic Drugs Market Sales Segment by Countries

      • 9.1.3 China

      • 9.1.4 Japan

      • 9.1.5 India

      • 9.1.6 South Korea

      • 9.1.7 Malaysia

      • 9.1.8 Vietnam

      • 9.1.9 Philippines

      • 9.1.10 Singapore

      • 9.1.11 Thailand

      • 9.1.12 Others

    • 9.2 Asia Biologic Drugs Market Segment (Product Type Level)

    • 9.3 Asia Biologic Drugs Market Segment (Application/Industry Level)

    • 9.4 Key Country Economy in Asia Pacific

    • 9.5 Analysis of Investment Attractiveness of Major Countries

    10 South America Biologic Drugs Market Segment Analysis and Investment Attractiveness

    • 10.1 South America Biologic Drugs Market Segment by Countries

      • 10.1.1 South America Biologic Drugs Market Revenue Segment by Countries

      • 10.1.2 South America Biologic Drugs Market Sales Segment by Countries

      • 10.1.3 Brazil

      • 10.1.4 Argentina

      • 10.1.5 Colombia

      • 10.1.6 Chile

      • 10.1.7 Others

    • 10.2 South America Biologic Drugs Market Segment (Product Type Level)

    • 10.3 South America Biologic Drugs Market Segment (Application/Industry Level)

    • 10.4 Key Country Economy in Asia Pacific

    • 10.5 Analysis of Investment Attractiveness of Major Countries

    11 Middle East Biologic Drugs Market Segment Analysis and Investment Attractiveness

    • 11.1 Middle East Biologic Drugs Market Segment by Countries

      • 11.1.1 Middle East Biologic Drugs Market Revenue Segment by Countries

      • 11.1.2 Middle East Biologic Drugs Market Sales Segment by Countries

      • 11.1.3 United Arab Emirates (UAE)

      • 11.1.4 Saudi Arabia

      • 11.1.5 Others

    • 11.2 Middle East Biologic Drugs Market Segment (Product Type Level)

    • 11.3 Middle East Biologic Drugs Market Segment (Application/Industry Level)

    • 11.4 Key Country Economy in Middle East

    • 11.5 Analysis of Investment Attractiveness of Major Countries

    12 Africa Biologic Drugs Market Segment Analysis and Investment Attractiveness

    • 12.1 Africa Biologic Drugs Market Segment by Countries

      • 12.1.1 Africa Biologic Drugs Market Revenue Segment by Countries

      • 12.1.2 Africa Biologic Drugs Market Sales Segment by Countries

      • 12.1.3 Nigeria

      • 12.1.4 Egypt

      • 12.1.5 South Africa

      • 12.1.6 Others

    • 12.2 Africa Biologic Drugs Market Segment (Product Type Level)

    • 12.3 Africa Biologic Drugs Market Segment (Application/Industry Level)

    • 12.4 Key Country Economy in Africa

    • 12.5 Analysis of Investment Attractiveness of Major Countries

    13 Oceania Biologic Drugs Market Segment Analysis and Investment Attractiveness

    • 13.1 Oceania Biologic Drugs Market Segment by Countries

      • 13.1.1 Oceania Biologic Drugs Market Revenue Segment by Countries

      • 13.1.2 Oceania Biologic Drugs Market Sales Segment by Countries

      • 13.1.3 Australia

      • 13.1.4 New Zealand

      • 13.1.5 Others

    • 13.2 Oceania Biologic Drugs Market Segment (Product Type Level)

    • 13.3 Oceania Biologic Drugs Market Segment (Application/Industry Level)

    • 13.4 Key Country Economy in Oceania

    • 13.5 Analysis of Investment Attractiveness of Major Countries

    14 Supply Chain Analysis

    • 14.1 Upstream Market Analysis

      • 14.1.1 Key Raw Materials Production Base and Market Concentration Rate

      • 14.1.2 Key Raw Materials Price Trend

    • 14.2 Biologic Drugs Production Analysis

      • 14.2.1 Manufacturing Cost Structure of Biologic Drugs

      • 14.2.2 Manufacturing Process Analysis of Biologic Drugs

      • 14.2.3 Source of Technology

      • 14.2.4 Competitive Landscape

    • 14.3 Downstream Market Analysis

      • 14.3.1 Customer Positioning Analysis

      • 14.3.2 Major Downstream Buyers of Biologic Drugs Analysis

    15 Market Influences Factors Analysis

    • 15.1 Changes from the Related Industries

    • 15.2 Substitutes Threat

    • 15.3 Customer Preference Change

    • 15.4 Upstream and Downstream Fluctuation

    • 15.5 COVID-19 Impact

      • 15.5.1 COVID-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

      • 15.5.2 Biologic Drugs Industry Market Status, Pre-COVID-19

      • 15.5.3 Biologic Drugs Industry Market Status, Post-COVID-19

      • 15.5.4 Impact of COVID-19 on Supply Chain

    • 15.6 Post-COVID-19 Biologic Drugs Industry Opportunity

    16 Key Research Findings


    The List of Tables and Figures

    • Figure Biologic Drugs Product Picture

    • Table Biologic Drugs Product Definition

    • Table Study Scope by Types

    • Figure Global Biologic Drugs Market Value by Type (2016 - 2026)

    • Table Study Scope by Application

    • Figure Global Biologic Drugs Market Value by Application (2016 - 2026)

    • Figure Global Biologic Drugs Market Size and Growth Rate from 2016 to 2026

    • Table Global Biologic Drugs Production Capacity by Manufacturers (2016-2021)

    • Table Global Biologic Drugs Production Capacity Market Share by Manufacturers (2016-2021)

    • Table Global Biologic Drugs Revenue by Manufacturers (2016-2021)

    • Table Global Biologic Drugs Revenue Market Share by Manufacturers (2016-2021)

    • Table Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • Table Manufacturers Biologic Drugs Plant Distribution and Sales Country

    • Table Roche - Company Business Overview

    • Figure Roche Total Revenue from 2018 to 2020

    • Table Roche Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Roche Sales and Growth Rate Analysis of Biologic Drugs

    • Figure Revenue and Market Share Analysis of Roche

    • Table Biologic Drugs Product Benchmarking

    • Table Johnson & Johnson - Company Business Overview

    • Figure Johnson & Johnson Total Revenue from 2018 to 2020

    • Table Johnson & Johnson Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Johnson & Johnson Sales and Growth Rate Analysis of Biologic Drugs

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Biologic Drugs Product Benchmarking

    • Table Pfizer - Company Business Overview

    • Figure Pfizer Total Revenue from 2018 to 2020

    • Table Pfizer Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Pfizer Sales and Growth Rate Analysis of Biologic Drugs

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Biologic Drugs Product Benchmarking

    • Table Sanofi - Company Business Overview

    • Figure Sanofi Total Revenue from 2018 to 2020

    • Table Sanofi Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Sanofi Sales and Growth Rate Analysis of Biologic Drugs

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Biologic Drugs Product Benchmarking

    • Table Amgen - Company Business Overview

    • Figure Amgen Total Revenue from 2018 to 2020

    • Table Amgen Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Amgen Sales and Growth Rate Analysis of Biologic Drugs

    • Figure Revenue and Market Share Analysis of Amgen

    • Table Biologic Drugs Product Benchmarking

    • Table Eli Lilly - Company Business Overview

    • Figure Eli Lilly Total Revenue from 2018 to 2020

    • Table Eli Lilly Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Eli Lilly Sales and Growth Rate Analysis of Biologic Drugs

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Biologic Drugs Product Benchmarking

    • Table Novartis - Company Business Overview

    • Figure Novartis Total Revenue from 2018 to 2020

    • Table Novartis Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Novartis Sales and Growth Rate Analysis of Biologic Drugs

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Biologic Drugs Product Benchmarking

    • Table Abbott Laboratories - Company Business Overview

    • Figure Abbott Laboratories Total Revenue from 2018 to 2020

    • Table Abbott Laboratories Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Abbott Laboratories Sales and Growth Rate Analysis of Biologic Drugs

    • Figure Revenue and Market Share Analysis of Abbott Laboratories

    • Table Biologic Drugs Product Benchmarking

    • Table Amgen - Company Business Overview

    • Figure Amgen Total Revenue from 2018 to 2020

    • Table Amgen Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Amgen Sales and Growth Rate Analysis of Biologic Drugs

    • Figure Revenue and Market Share Analysis of Amgen

    • Table Biologic Drugs Product Benchmarking

    • Table Eli Lilly - Company Business Overview

    • Figure Eli Lilly Total Revenue from 2018 to 2020

    • Table Eli Lilly Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Eli Lilly Sales and Growth Rate Analysis of Biologic Drugs

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Biologic Drugs Product Benchmarking

    • Table Purchasing Strategy based on Purchasing Positioning Model

    • Table Global Biologic Drugs Market Revenue by Types (Historical)

    • Table Global Biologic Drugs Market Revenue Market Share by Types (Historical)

    • Figure Global Revenue and Growth Rate of Humira 2016-2021

    • Figure Global Revenue and Growth Rate of Remicade 2016-2021

    • Figure Global Revenue and Growth Rate of Rituxan 2016-2021

    • Figure Global Revenue and Growth Rate of Enbrel 2016-2021

    • Figure Global Revenue and Growth Rate of Lantus 2016-2021

    • Figure Global Revenue and Growth Rate of Avastin 2016-2021

    • Figure Global Revenue and Growth Rate of Herceptin 2016-2021

    • Figure Global Revenue and Growth Rate of Others 2016-2021

    • Table Global Biologic Drugs Market Sales by Types (Historical)

    • Table Global Biologic Drugs Market Sales Market Share by Types (Historical)

    • Figure Global Sales and Growth Rate of Humira 2016-2021

    • Figure Global Sales and Growth Rate of Remicade 2016-2021

    • Figure Global Sales and Growth Rate of Rituxan 2016-2021

    • Figure Global Sales and Growth Rate of Enbrel 2016-2021

    • Figure Global Sales and Growth Rate of Lantus 2016-2021

    • Figure Global Sales and Growth Rate of Avastin 2016-2021

    • Figure Global Sales and Growth Rate of Herceptin 2016-2021

    • Figure Global Sales and Growth Rate of Others 2016-2021

    • Table Global Biologic Drugs Market Revenue by Types (Forecast)

    • Table Global Biologic Drugs Market Revenue Market Share by Types (Forecast)

    • Table Global Biologic Drugs Market Sales by Types (Forecast)

    • Table Global Biologic Drugs Market Sales Market Share by Types (Forecast)

    • Figure Global Biologic Drugs Market Price By Type from 2016 to 2026

    • Table Downstream Industry Demand Analysis for Biologic Drugs

    • Table Global Biologic Drugs Market Revenue by Application (Historical)

    • Table Global Biologic Drugs Market Revenue Market Share by Application (Historical)

    • Figure Global Revenue and Growth Rate of Diabetes 2016-2021

    • Figure Global Revenue and Growth Rate of Inflammation 2016-2021

    • Figure Global Revenue and Growth Rate of Auto-Immune Diseases 2016-2021

    • Figure Global Revenue and Growth Rate of Blood Diseases 2016-2021

    • Figure Global Revenue and Growth Rate of Cardiovascular Diseases 2016-2021

    • Figure Global Revenue and Growth Rate of Others 2016-2021

    • Table Global Biologic Drugs Market Sales by Application (Historical)

    • Table Global Biologic Drugs Market Sales Market Share by Application (Historical)

    • Figure Global Sales and Growth Rate of Diabetes 2016-2021

    • Figure Global Sales and Growth Rate of Inflammation 2016-2021

    • Figure Global Sales and Growth Rate of Auto-Immune Diseases 2016-2021

    • Figure Global Sales and Growth Rate of Blood Diseases 2016-2021

    • Figure Global Sales and Growth Rate of Cardiovascular Diseases 2016-2021

    • Figure Global Sales and Growth Rate of Others 2016-2021

    • Table Global Biologic Drugs Market Revenue by Application (Forecast)

    • Table Global Biologic Drugs Market Revenue Market Share by Application (Forecast)

    • Table Global Biologic Drugs Market Sales by Application (Forecast)

    • Table Global Biologic Drugs Market Sales Market Share by Application (Forecast)

    • Table Global Biologic Drugs Market Revenue by Geography (Historical)

    • Table Global Biologic Drugs Market Revenue Market Share by Geography (Historical)

    • Figure Global Biologic Drugs Revenue Market Share by Geography in 2020

    • Table Global Biologic Drugs Market Sales by Geography (Historical)

    • Table Global Biologic Drugs Market Sales Market Share by Geography (Historical)

    • Figure Global Biologic Drugs Sales Market Share by Geography in 2020

    • Table Global Biologic Drugs Market Revenue by Geography (Forecast)

    • Table Global Biologic Drugs Market Revenue Market Share by Geography (Forecast)

    • Table Global Biologic Drugs Market Sales by Geography (Forecast)

    • Table Global Biologic Drugs Market Sales Market Share by Geography (Forecast)

    • Figure Top Sales Country Geographical Advantage Analysis

    • Table North America Biologic Drugs Revenue by Countries from 2016 to 2026

    • Table North America Biologic Drugs Revenue Market Share by Countries from 2016 to 2026

    • Figure North America Biologic Drugs Revenue Market Share by Major Countries in 2020

    • Table North America Biologic Drugs Sales by Countries from 2016 to 2026

    • Table North America Biologic Drugs Sales Market Share by Countries from 2016 to 2026

    • Figure North America Biologic Drugs Sales Market Share by Major Countries in 2020

    • Figure USA Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure USA Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Canada Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Canada Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Mexico Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Mexico Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Table North America Biologic Drugs Sales by Types from 2016 to 2026

    • Table North America Biologic Drugs Sales Market Share by Types from 2016 to 2026

    • Table North America Biologic Drugs Value by Types from 2016 to 2026

    • Table North America Biologic Drugs Value Market Share by Types from 2016 to 2026

    • Table North America Biologic Drugs Sales by Application from 2016 to 2026

    • Table North America Biologic Drugs Sales Market Share by Application from 2016 to 2026

    • Table North America Biologic Drugs Value by Application from 2016 to 2026

    • Table North America Biologic Drugs Value Market Share by Application from 2016 to 2026

    • Table Europe Biologic Drugs Revenue by Countries from 2016 to 2026

    • Table Europe Biologic Drugs Revenue Market Share by Countries from 2016 to 2026

    • Figure Europe Biologic Drugs Revenue Market Share by Major Countries in 2020

    • Table Europe Biologic Drugs Sales by Countries from 2016 to 2026

    • Table Europe Biologic Drugs Sales Market Share by Countries from 2016 to 2026

    • Figure Europe Biologic Drugs Sales Market Share by Major Countries in 2020

    • Figure Germany Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Germany Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure United Kingdom Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure United Kingdom Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure France Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure France Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Italy Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Italy Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Russia Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Russia Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Spain Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Spain Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Netherlands Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Netherlands Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Switzerland Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Switzerland Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Turkey Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Turkey Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Poland Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Poland Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Sweden Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Sweden Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Belgium Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Belgium Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Austria Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Austria Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Others Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Table Europe Biologic Drugs Sales by Types from 2016 to 2026

    • Table Europe Biologic Drugs Sales Market Share by Types from 2016 to 2026

    • Table Europe Biologic Drugs Value by Types from 2016 to 2026

    • Table Europe Biologic Drugs Value Market Share by Types from 2016 to 2026

    • Table Europe Biologic Drugs Sales by Application from 2016 to 2026

    • Table Europe Biologic Drugs Sales Market Share by Application from 2016 to 2026

    • Table Europe Biologic Drugs Value by Application from 2016 to 2026

    • Table Europe Biologic Drugs Value Market Share by Application from 2016 to 2026

    • Table Asia Biologic Drugs Revenue by Countries from 2016 to 2026

    • Table Asia Biologic Drugs Revenue Market Share by Countries from 2016 to 2026

    • Figure Asia Biologic Drugs Revenue Market Share by Major Countries in 2020

    • Table Asia Biologic Drugs Sales by Countries from 2016 to 2026

    • Table Asia Biologic Drugs Sales Market Share by Countries from 2016 to 2026

    • Figure Asia Biologic Drugs Sales Market Share by Major Countries in 2020

    • Figure China Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure China Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Japan Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Japan Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure India Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure India Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure South Korea Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure South Korea Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Malaysia Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Malaysia Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Vietnam Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Vietnam Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Philippines Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Philippines Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Singapore Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Singapore Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Thailand Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Thailand Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Others Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Table Asia Biologic Drugs Sales by Types from 2016 to 2026

    • Table Asia Biologic Drugs Sales Market Share by Types from 2016 to 2026

    • Table Asia Biologic Drugs Value by Types from 2016 to 2026

    • Table Asia Biologic Drugs Value Market Share by Types from 2016 to 2026

    • Table Asia Biologic Drugs Sales by Application from 2016 to 2026

    • Table Asia Biologic Drugs Sales Market Share by Application from 2016 to 2026

    • Table Asia Biologic Drugs Value by Application from 2016 to 2026

    • Table Asia Biologic Drugs Value Market Share by Application from 2016 to 2026

    • Table South America Biologic Drugs Revenue by Countries from 2016 to 2026

    • Table South America Biologic Drugs Revenue Market Share by Countries from 2016 to 2026

    • Figure South America Biologic Drugs Revenue Market Share by Major Countries in 2020

    • Table South America Biologic Drugs Sales by Countries from 2016 to 2026

    • Table South America Biologic Drugs Sales Market Share by Countries from 2016 to 2026

    • Figure South America Biologic Drugs Sales Market Share by Major Countries in 2020

    • Figure Brazil Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Brazil Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Argentina Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Argentina Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Colombia Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Colombia Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Chile Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Chile Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Others Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Table South America Biologic Drugs Sales by Types from 2016 to 2026

    • Table South America Biologic Drugs Sales Market Share by Types from 2016 to 2026

    • Table South America Biologic Drugs Value by Types from 2016 to 2026

    • Table South America Biologic Drugs Value Market Share by Types from 2016 to 2026

    • Table South America Biologic Drugs Sales by Application from 2016 to 2026

    • Table South America Biologic Drugs Sales Market Share by Application from 2016 to 2026

    • Table South America Biologic Drugs Value by Application from 2016 to 2026

    • Table South America Biologic Drugs Value Market Share by Application from 2016 to 2026

    • Table Middle East Biologic Drugs Revenue by Countries from 2016 to 2026

    • Table Middle East Biologic Drugs Revenue Market Share by Countries from 2016 to 2026

    • Figure Middle East Biologic Drugs Revenue Market Share by Major Countries in 2020

    • Table Middle East Biologic Drugs Sales by Countries from 2016 to 2026

    • Table Middle East Biologic Drugs Sales Market Share by Countries from 2016 to 2026

    • Figure Middle East Biologic Drugs Sales Market Share by Major Countries in 2020

    • Figure United Arab Emirates (UAE) Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure United Arab Emirates (UAE) Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Others Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Table Middle East Biologic Drugs Sales by Types from 2016 to 2026

    • Table Middle East Biologic Drugs Sales Market Share by Types from 2016 to 2026

    • Table Middle East Biologic Drugs Value by Types from 2016 to 2026

    • Table Middle East Biologic Drugs Value Market Share by Types from 2016 to 2026

    • Table Middle East Biologic Drugs Sales by Application from 2016 to 2026

    • Table Middle East Biologic Drugs Sales Market Share by Application from 2016 to 2026

    • Table Middle East Biologic Drugs Value by Application from 2016 to 2026

    • Table Middle East Biologic Drugs Value Market Share by Application from 2016 to 2026

    • Table Africa Biologic Drugs Revenue by Countries from 2016 to 2026

    • Table Africa Biologic Drugs Revenue Market Share by Countries from 2016 to 2026

    • Figure Africa Biologic Drugs Revenue Market Share by Major Countries in 2020

    • Table Africa Biologic Drugs Sales by Countries from 2016 to 2026

    • Table Africa Biologic Drugs Sales Market Share by Countries from 2016 to 2026

      • Figure Africa Biologic Drugs Sales Market Share by Major Countries in 2020

    • Figure Nigeria Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Nigeria Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Egypt Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Egypt Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure South Africa Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure South Africa Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Others Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Table Africa Biologic Drugs Sales by Types from 2016 to 2026

    • Table Africa Biologic Drugs Sales Market Share by Types from 2016 to 2026

    • Table Africa Biologic Drugs Value by Types from 2016 to 2026

    • Table Africa Biologic Drugs Value Market Share by Types from 2016 to 2026

    • Table Africa Biologic Drugs Sales by Application from 2016 to 2026

    • Table Africa Biologic Drugs Sales Market Share by Application from 2016 to 2026

    • Table Africa Biologic Drugs Value by Application from 2016 to 2026

    • Table Africa Biologic Drugs Value Market Share by Application from 2016 to 2026

    • Table Oceania Biologic Drugs Revenue by Countries from 2016 to 2026

    • Table Oceania Biologic Drugs Revenue Market Share by Countries from 2016 to 2026

    • Figure Oceania Biologic Drugs Revenue Market Share by Major Countries in 2020

    • Table Oceania Biologic Drugs Sales by Countries from 2016 to 2026

    • Table Oceania Biologic Drugs Sales Market Share by Countries from 2016 to 2026

    • Figure Oceania Biologic Drugs Sales Market Share by Major Countries in 2020

    • Figure Australia Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Australia Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure New Zealand Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure New Zealand Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Biologic Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Others Biologic Drugs Market Volume and Growth Rate from 2016 to 2026

    • Table Oceania Biologic Drugs Sales by Types from 2016 to 2026

    • Table Oceania Biologic Drugs Sales Market Share by Types from 2016 to 2026

    • Table Oceania Biologic Drugs Value by Types from 2016 to 2026

    • Table Oceania Biologic Drugs Value Market Share by Types from 2016 to 2026

    • Table Oceania Biologic Drugs Sales by Application from 2016 to 2026

    • Table Oceania Biologic Drugs Sales Market Share by Application from 2016 to 2026

    • Table Oceania Biologic Drugs Value by Application from 2016 to 2026

    • Table Oceania Biologic Drugs Value Market Share by Application from 2016 to 2026

    • Table Production Base and Market Concentration Rate of Raw Material

    • Figure Key Raw Materials Price Trend

    • Figure Manufacturing Process Analysis of Biologic Drugs

    • Figure Top 10 Market Share in 2020

    • Table Major Downstream Buyers of Biologic Drugs with Contact Information


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US